Validity and Reliability of the GPCOG -TR

NCT05704452 | Unknown

• 1 other identifier: GPCOG Validity
• Study Type: observational
• Target: 230
• Locations: 1 country
• Sites: 1

Brief Summary

The General Practitioner assessment of Cognition (GPCOG) was specifically developed as a brief cognitive screening tool to be used by general practitioners (GPs). It consists of a patient section testing cognition and an informant section asking historical questions. The aim of this study was to test the validity and reliability of the Turkish version of GPCOG-TR on Turkish older adults.

Conditions

Dementia

Keywords

General Practitioners; Early diagnosis

Outcome Measures

Primary Outcomes (2)

• The Clinical Dementia Rating score (CDR)

  The scoring system from 0 to 3 ( 0 means healthy while 3 Severe dementia )

  1-2 hrs

• the General Practitioner Cognitive Assessment tool (GPCOG-TR)

  Total score: 15 * 9 for the patient part * 6 for the informant part ( The lower the score the more serious is the cognition is)

  10 min

Secondary Outcomes (3)

• The Mini-mental State Examination (MMSE)

  10 min

• Alzheimer's Disease Assessment Scale-Cognitive scale (ADAS-Cog)

  30 min

• Geriatric Depression Scale (GDS)

  5 min

Study Arms (2)

Patient group

who diagnosed with dementia

Control group

who diagnosed as healthy (don't have dementia)

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Age Groups: Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

The participants of this study were members of the Neurology Department of Maltepe University Medical Faculty Hospital.

You may qualify if:

• Age: least 55 years old
• Provide informed consent
• Diagnosed with dementia ( patient group)

You may not qualify if:

• Living in a nursing home
• Presence of psychiatric disorders requiring treatment
• Presence of other comorbidity interfering with cognitive performance such as severe chronic heart failure, chronic obstructive pulmonary disease, diabetes, anemia Impairment of auditory or visual perception
• Low education
• Known cognitive impairment (for control group only)
• Lack of a reliable informant.

Sponsors & Collaborators

• Yeditepe University: lead

Study Sites (1)

Yeditepe University

Istanbul, Ataşehir, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Dementia; Disease

Condition Hierarchy (Ancestors)

Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurocognitive Disorders; Mental Disorders; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Aber Ahmetoğlu, Master student

CONTACT

536 213 49 30; aber.ahmetoglu@std.yeditepe.edu.tr

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 19, 2023
• First Posted: January 30, 2023
• Study Start: December 6, 2022
• Primary Completion: February 20, 2023
• Study Completion: March 26, 2023
• Last Updated: February 15, 2023

Record last verified: 2023-01

Locations

TU (1)